LeMaitre Vascular Inc  

(Public, NASDAQ:LMAT)   Watch this stock  
Find more results for Pruitt
14.41
+0.06 (0.42%)
Jul 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 14.23 - 14.64
52 week 11.01 - 18.44
Open 14.41
Vol / Avg. 0.00/89,851.00
Mkt cap 265.95M
P/E 31.62
Div/yield 0.05/1.25
EPS 0.46
Shares 18.38M
Beta 0.41
Inst. own 59%
Jul 27, 2016
Q2 2016 LeMaitre Vascular Inc Earnings Call - 5:00PM EDT - Add to calendar
Jul 27, 2016
Q2 2016 LeMaitre Vascular Inc Earnings Release - 4:00PM EDT - Add to calendar
Jun 28, 2016
LeMaitre Vascular Inc at Three Part Advisors East Coast IDEAS Investor Conference
May 2, 2016
Q1 2016 LeMaitre Vascular Inc Earnings Call - Webcast
May 2, 2016
Q1 2016 LeMaitre Vascular Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 10.69% 9.90%
Operating margin 16.29% 14.69%
EBITD margin - 18.57%
Return on average assets 9.44% 9.01%
Return on average equity 10.96% 10.62%
Employees 339 -
CDP Score - -

Address

63 2nd Ave
BURLINGTON, MA 01803-4413
United States - Map
+1-781-2212266 (Phone)
+1-781-4255049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Officers and directors

George W. LeMaitre Chairman of the Board, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David B. Roberts President, Director
Age: 51
Bio & Compensation  - Reuters
Joseph P. Pellegrino Jr. Chief Financial Officer
Age: 50
Bio & Compensation  - Reuters
Peter R. Gebauer President - International Operations
Age: 61
Bio & Compensation  - Reuters
Trent G. Kamke Senior Vice President - Operations
Age: 44
Bio & Compensation  - Reuters
Michael T Wijas Vice President - Sales, Americas
Bio & Compensation  - Reuters
Cornelia W. LeMaitre Vice President - Human Resources, Director
Age: 79
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Lawrence J. Jasinski Independent Director
Age: 57
Bio & Compensation  - Reuters
John J. O'Connor Independent Director
Age: 67
Bio & Compensation  - Reuters
John A. Roush Independent Director
Age: 51
Bio & Compensation  - Reuters